Researchers further illuminate pathway for treatment of cystic fibrosis

New research findings add further clarity to a question that has polarized the cystic fibrosis (CF) research community. It is well established that people with cystic fibrosis have two faulty copies of the CFTR gene, but debate continues on the question of whether certain symptoms of the airway disease are caused by the mutation or if the genetic defect precedes, but does not directly lead to some of the worst symptoms patients face.

Read the whole article on Science Daily

More from Science Daily